跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FIBSOL 5 lisinopril 5mg (as dihydrate) tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
FIBSOL 5 lisinopril 5mg (as dihydrate) tablet blister pack
Approved
STANDARD
FIBSOL 5 lisinopril 5mg (as dihydrate) tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e06412affb5c65b1
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
e06412affb5c65b1
Product Name
FIBSOL 5 lisinopril 5mg (as dihydrate) tablet blister pack
Artg Id
101316
Artg Name
FIBSOL 5 lisinopril 5mg (as dihydrate) tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2004-05-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/6d93995a6117f8cf3b863827589abfe8.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/e2ee299b9f5312b3d02fbfb74289c040.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e06412affb5c65b1
Type
Standard
Back to TGA Approvals